Treatment with anti-CD154 antibody and donor specific transfusion prevents acute rejection of myoblast transplantation

Transplantation

Volumn 73, Issue 3, 2002, Pages 453-461

  Camirand, Geoffrey ^a   Caron, Nicolas J ^a   Turgeon, Nicole A ^a   Rossini, Aldo A ^a   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; MONOCLONAL ANTIBODY;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

EID: 0037084051     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202150-00021     Document Type: Article

References (51)

1. Regeneration of skeletal muscle induced by satellite cell grafts
2. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation
3. Conversion of mdx myofibres from dystrophin-negative to-positive by injection of normal myoblasts
4. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions
5. Antibody formation after myoblast transplantation in Duchenne-dystrophic patients, donor HLA compatible
6. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mice
7. Cellular and molecular reactions in mouse muscles after myoblast implantation
8. Induction of immunologic tolerance for transplantation
9. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand
10. Induction of immunological tolerance to islet allografts
11. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand
12. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation
13. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154
14. Molecular and biological characterization of a murine ligand for CD40
15. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells
16. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation
17. Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity
18. Induction of human IgE synthesis in B cells by mast cells and basophils
19. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2
20. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo
21. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
22. CD40 and CD154 in cell-mediated immunity
23. Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody
24. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner
25. In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles. A comparison with embryonic myogenic cells
26. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD
27. Proceedings. Histological and histochemical aspects of the effect of notexin on rat skeletal muscle
28. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39
29. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells
30. Increased granzyme B mRNA after alloincompatible myoblast transplantation
31. Male-specific competitive PCR for the quantification of transplanted cells in mice
32. Complex fiber-type-specific expression of fast skeletal muscle troponin I gene constructs in transgenic mice
33. Progress in myoblast transplantation: A potential treatment of dystrophies
34. Successful histocompatible myoblast transplantation in dystrophin- deficient mdx mouse despite the production of antibodies against dystrophin
35. The nephrotoxicity of new and old immunosuppressive drugs
36. Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression
37. Evaluation of neurotoxicity in pediatric renal transplant recipients treated with tacrolimus (FK506)
38. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4
39. Interleukin-2: Inception, impact, and implications
40. Cell-mediated cytotoxicity
41. Interferon-gamma, prototype of the proinflammatory cytokines- importance in activation, suppression, and maintenance of the immune response
42. Perforin and granzyme B expression is associated with severe acute rejection. Evidence for in situ localization in alveolar lymphocytes of lung-transplanted patients
43. Cell specificity of granzyme gene expression
44. "Infectious" transplantation tolerance
45. Cutting edge: Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance
46. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression
47. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders
48. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles
49. Mixed chimerism as an approach for the induction of transplantation tolerance
50. Humoral immune responses in CD40 ligand-deficient mice
51. + cells